Sera Prognostics Completes Enrollment of Large, Multicenter, Prospective Clinical Study of PreTRM® Test
November 27, 2018 08:00 ET
|
Sera Prognostics, Inc.
TREETOP Study will Explore Enhancements to Sera’s Validated PreTRM® Test SALT LAKE CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company, announced today that...
Sera Prognostics to Present at the 11th Annual Canaccord Genuity Medical Technologies and Diagnostics Forum
November 06, 2017 10:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics to Present at the Baird 2017 Global Healthcare Conference
September 05, 2017 10:49 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive...
Sera Prognostics Receives Accreditation from College of American Pathologists
June 29, 2017 09:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, June 29, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that the Accreditation Committee of the College of American Pathologists (CAP)...
Sera Prognostics is Named a 2017 Silver Edison Award Winner
April 21, 2017 07:00 ET
|
Sera Prognostics, Inc.
NEW YORK, April 21, 2017 (GLOBE NEWSWIRE) -- The Edison Awards, celebrating 30 years of honoring the best in innovation and excellence in the development of new products and services, announced...
Sera Prognostics’ PreTRM® Test Wins 2016 Utah Innovation Award in Life Sciences
May 12, 2016 14:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, May 12, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company, today announced that it was selected as the 2016 Utah Innovation Award winner in the Life Science –...
Landmark Study Published in American Journal of Obstetrics & Gynecology Validates New Blood Test as Objective, Predictive Tool for Preterm Birth Risk
March 10, 2016 07:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 10, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that clinical validation data from the 5,501 patient Proteomic Assessment of...
Positive Clinical Validation Data for PreTRM® Test Presented at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting
February 04, 2016 15:15 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that results from the 5,501-patient Proteomic Assessment of Preterm Risk...